Hong Kong Pharma Appoints New Independent Director
Ticker: HKPD · Form: 6-K · Filed: Sep 11, 2025 · CIK: 2007702
Sentiment: neutral
Topics: corporate-governance, board-appointment
TL;DR
HK Pharma adds Zhou Mike Yao as independent director, effective Sept 9.
AI Summary
Hong Kong Pharma Digital Technology Holdings Limited announced on September 9, 2025, the appointment of Mr. Zhou Mike Yao as an independent director to its Board. This appointment is effective immediately and is part of the company's ongoing governance and operational updates.
Why It Matters
The appointment of an independent director can signal a commitment to stronger corporate governance and potentially improve oversight and strategic decision-making.
Risk Assessment
Risk Level: low — This filing is a routine corporate announcement regarding a board appointment and does not involve financial transactions or significant operational changes.
Key Players & Entities
- Hong Kong Pharma Digital Technology Holdings Limited (company) — Registrant
- Mr. Zhou Mike Yao (person) — Appointed Independent Director
- September 9, 2025 (date) — Effective date of appointment
FAQ
Who was appointed as an independent director?
Mr. Zhou Mike Yao was appointed as an independent director.
When was the appointment effective?
The appointment was effective September 9, 2025.
What is the name of the company filing this report?
The company filing this report is Hong Kong Pharma Digital Technology Holdings Limited.
What form is being filed?
A Form 6-K, Report of Foreign Private Issuer, is being filed.
What is the company's principal executive office address?
The principal executive office is located at Room B1, 5/F., Well Town Industrial Building, 13 Ko Fai Road, Yau Tong, Kowloon, Hong Kong.
Filing Stats: 561 words · 2 min read · ~2 pages · Grade level 10 · Accepted 2025-09-11 08:30:22
Key Financial Figures
- $100,000 — ay Mr. Zhou an annual compensation of HK$100,000, payable in arrears, in equal installme
Filing Documents
- ea0253921-6k_hongkong.htm (6-K) — 13KB
- 0001213900-25-086676.txt ( ) — 14KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. HONG KONG PHARMA DIGITAL TECHNOLOGY HOLDINGS LIMITED By: /s/ Lap Sun Wong Name: Lap Sun Wong Title: Chief Executive Officer and Chairman Date: September 11, 2025 2